Search results for “Tyrosine-kinase inhibitor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 10,266 patents, we discovered top 463 key players by total patent application. Novartis AG, Vertex Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 13.20% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 603
Massachusetts, United States
Patent: 463
Switzerland
Patent: 289
CITY OF HAMILTON, Bermuda
Patent: 283
Colorado, United States
Patent: 281
New York, United States
Patent: 256
Scientic, Inc.
Alabama, United States
Patent: 250
California, United States
Patent: 248
Jiangsu Sheng, China
Patent: 232
New Jersey, United States
Patent: 225
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 147 patents, we discovered top 24 start-ups by total patent application. Capella Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale, Shanghai KeChow Pharmaceuticals Co., Ltd. are active in this area.
STARTUP
California, United States
Patent: 33
STARTUP
France
Patent: 24
STARTUP
Shanghai Shi, China
Patent: 14
STARTUP
South Korea
Patent: 11
STARTUP
South Korea
Patent: 9
STARTUP
California, United States
Patent: 7
STARTUP
United States
Patent: 6
STARTUP
Jiangsu Sheng, China
Patent: 5
STARTUP
Baden-Württemberg, Germany
Patent: 5
STARTUP
California, United States
Patent: 4
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 1,722 patents applied in the last 5 years. We discover 446 most active companies in this area. The fast-growing The Board of Regents of The University of Texas System, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Janssen Pharmaceutica NV take 12.78% of patent filing during this period.
The Board of Regents of The University of Texas System
Texas, United States
Patent: 87
Jiangsu Sheng, China
Patent: 68
Antwerpen, Belgium
Patent: 65
California, United States
Patent: 55
Jiangsu Sheng, China
Patent: 52
Switzerland
Patent: 39
California, United States
Patent: 32
New York, United States
Patent: 31
South Korea
Patent: 31
Massachusetts, United States
Patent: 29
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 1,722 patents in last 5 years, we discover 245 new entrants. Ocular Therapeutix, Inc., Black Diamond Therapeutics, Inc., Genzyme Corp. are the most active new entrants in this area.
Massachusetts, United States
Patent: 19
Massachusetts, United States
Patent: 15
Massachusetts, United States
Patent: 12
Henan Sheng, China
Patent: 11
Crystal Pharmaceutical (Suzhou) Co., Ltd
Jiangsu Sheng, China
Patent: 10
Shanghai Shi, China
Patent: 9
Delaware, United States
Patent: 7
Singapore
Patent: 7
Utah, United States
Patent: 7
STARTUP
California, United States
Patent: 7
Research Institutions
Order by:
Innovation Intensity
With the analysis among 1,241 patents, we discovered top 160 universities and scientific research institutions by total patent application. The Scripps Research Institute, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Korea Institute of Science & Technology are dominant in this area. They take 23.69% of the total patent filing.
California, United States
Patent: 103
Shanghai Shi, China
Patent: 47
South Korea
Patent: 40
Connecticut, United States
Patent: 29
Georgia, United States
Patent: 19
Colorado, United States
Patent: 14
Pennsylvania, United States
Patent: 13
Georgetown University School of Medicine
District of Columbia, United States
Patent: 13
Tokyo-to, Japan
Patent: 12
Liaoning Sheng, China
Patent: 12
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: